Zhe Amy Fang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhe Amy Fang has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
James A. DiNardo
Divison of Cardiac Anesthesia, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA
3 shared publicationsBradley S. Marino
2 shared publications- Jun Teruya
Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas
2 shared publications - Abby Victoria Winterberg
Anesthesiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
1 shared publication - Alexander J.C. Mittnacht
Department of Anesthesiology, New York Medical College, Westchester Medical Center, Valhalla, NY
1 shared publication Amir Hassan Navaei
Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas
1 shared publication
Latest Publications
- 10 July 2026
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (12) , 4066-4071
Cerebral Autoregulation During Antegrade Cerebral Perfusion in Neonates Undergoing Congenital Cardiac Surgery
- 10 July 2026
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (12) , 4066-4071
Cerebral Autoregulation During Antegrade Cerebral Perfusion in Neonates Undergoing Congenital Cardiac Surgery
- Open Access
- 27 June 2025
- Published by Wiley in Pediatric Anesthesia
Retrospective Review of Intraoperative Hypotension and Perioperative Angiotensin Inhibitor Use in Pediatrics
Background: Perioperative management of angiotensin inhibitors is contentious in adults and understudied in children. Perioperative angiotensin inhibitor management in pediatrics cannot be extrapolated from adult literature because of dynamic neurohormonal pediatric physiology and uniquely pediatric indications for angiotensin inhibitor therapy. There is limited evidence for whether angiotensin inhibitors should be held in the perioperative setting in the pediatric population.Aims: The aim of this study is to assess whether perioperative angiotensin inhibitor use is associated with intraoperative hypotension in the pediatric population.Methods: This is a single center, retrospective cohort study. Data collection comprised demographics, angiotensin inhibitor dose timing and intraoperative blood pressure. Participants patients were divided into two groups based on recency of dose of angiotensin inhibitor, Recents had angiotensin inhibitor therapy within 2 days and Remotes had angiotensin inhibitor therapy between 2 and 30 days. Logistic regression with covariate adjustment and propensity score matching were performed to control confounding. Regression analysis and Chi‐squared test were used to compare the incidence of hypotension between the two groups.Results: Four hundred ninety patients were included in the study prior to propensity score matching. We found the overall incidence of hypotension to be 29% (142/490). There was no difference in the incidence of hypotension by recency of angiotensin inhibitor dose between the two groups prior to matching, Recents 25.4% (59/232), Remotes 32% (83/258), p = 0.06. Adjusting for covariates, the odds ratio for hypotension is 0.73 (0.48–1.10, p = 0.129) for Recents compared to Remotes. After propensity score matching, there were 184 patients in each group. There remained no difference in the incidence of hypotension in the between the two groups, Recents 27% (50/184), Remotes 33% (61/184), p = 0.13.Conclusion: We found no evidence to support the practice of abstaining from angiotensin inhibitor use in pediatric surgical patients for concern of intraoperative hypotension.
- 27 June 2025
- Published by Wiley in Pediatric Anesthesia
Open AccessRetrospective Review of Intraoperative Hypotension and Perioperative Angiotensin Inhibitor Use in Pediatrics
Background: Perioperative management of angiotensin inhibitors is contentious in adults and understudied in children. Perioperative angiotensin inhibitor management in pediatrics cannot be extrapolated from adult literature because of dynamic neurohormonal pediatric physiology and uniquely pediatric indications for angiotensin inhibitor therapy. There is limited evidence for whether angiotensin inhibitors should be held in the perioperative setting in the pediatric population.Aims: The aim of this study is to assess whether perioperative angiotensin inhibitor use is associated with intraoperative hypotension in the pediatric population.Methods: This is a single center, retrospective cohort study. Data collection comprised demographics, angiotensin inhibitor dose timing and intraoperative blood pressure. Participants patients were divided into two groups based on recency of dose of angiotensin inhibitor, Recents had angiotensin inhibitor therapy within 2 days and Remotes had angiotensin inhibitor therapy between 2 and 30 days. Logistic regression with covariate adjustment and propensity score matching were performed to control confounding. Regression analysis and Chi‐squared test were used to compare the incidence of hypotension between the two groups.Results: Four hundred ninety patients were included in the study prior to propensity score matching. We found the overall incidence of hypotension to be 29% (142/490). There was no difference in the incidence of hypotension by recency of angiotensin inhibitor dose between the two groups prior to matching, Recents 25.4% (59/232), Remotes 32% (83/258), p = 0.06. Adjusting for covariates, the odds ratio for hypotension is 0.73 (0.48–1.10, p = 0.129) for Recents compared to Remotes. After propensity score matching, there were 184 patients in each group. There remained no difference in the incidence of hypotension in the between the two groups, Recents 27% (50/184), Remotes 33% (61/184), p = 0.13.Conclusion: We found no evidence to support the practice of abstaining from angiotensin inhibitor use in pediatric surgical patients for concern of intraoperative hypotension.
- 1 October 2021
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 35 (10) , 2848-2854
Selected 2020 Highlights in Congenital Cardiac Anesthesia
- 1 October 2021
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 35 (10) , 2848-2854
Selected 2020 Highlights in Congenital Cardiac Anesthesia
- 17 September 2020
- Published by Wiley in Transfusion
- Vol. 60 (12) , 2841-2848
Low antithrombin levels in neonates and infants undergoing congenital heart surgery result in more red blood cell and plasma transfusion on cardiopulmonary bypass
Background: Neonates have lower levels of antithrombin (AT) due to immature liver synthetic function. AT deficiency may lead to inadequate anticoagulation with heparin during cardiac surgery resulting in consumption of coagulation factors and increased blood transfusion. The goal of this study is to examine the effect of AT level on the transfusion requirements of neonates and infants undergoing open heart surgery.Study Design and Methods: This is a prospective, observational study at a tertiary pediatric referral center. Neonates and infants up to 6 months of age undergoing congenital heart surgery with cardiopulmonary bypass (CPB) were enrolled. Demographic, intraoperative, transfusion, and complications data were collected. Preoperative AT level was measured after induction of anesthesia. Prior to separation from CPB, a second blood sample was drawn and AT, thrombin antithrombin complex (TAT), D‐dimer, and anti‐Xa levels were measured. Linear and logistic regression were performed for data analysis.Results: Preoperative low AT level was significantly associated with increased transfusion of red blood cells (RBCs) and fresh frozen plasma (FFP) during CPB, but not after separation from CPB. The incidence of thrombosis and re‐operation were not associated with preoperative AT levels. There was no association between TAT, D‐dimer, and anti‐Xa levels at the end of CPB and preoperative AT levels.Conclusion: Low preoperative AT level is associated with increased transfusion of RBC and FFP on CPB in neonates and infants undergoing congenital heart surgery. Low preoperative AT level did not result in coagulation activation after CPB and after surgery.
- 17 September 2020
- Published by Wiley in Transfusion
- Vol. 60 (12) , 2841-2848
Low antithrombin levels in neonates and infants undergoing congenital heart surgery result in more red blood cell and plasma transfusion on cardiopulmonary bypass
Background: Neonates have lower levels of antithrombin (AT) due to immature liver synthetic function. AT deficiency may lead to inadequate anticoagulation with heparin during cardiac surgery resulting in consumption of coagulation factors and increased blood transfusion. The goal of this study is to examine the effect of AT level on the transfusion requirements of neonates and infants undergoing open heart surgery.Study Design and Methods: This is a prospective, observational study at a tertiary pediatric referral center. Neonates and infants up to 6 months of age undergoing congenital heart surgery with cardiopulmonary bypass (CPB) were enrolled. Demographic, intraoperative, transfusion, and complications data were collected. Preoperative AT level was measured after induction of anesthesia. Prior to separation from CPB, a second blood sample was drawn and AT, thrombin antithrombin complex (TAT), D‐dimer, and anti‐Xa levels were measured. Linear and logistic regression were performed for data analysis.Results: Preoperative low AT level was significantly associated with increased transfusion of red blood cells (RBCs) and fresh frozen plasma (FFP) during CPB, but not after separation from CPB. The incidence of thrombosis and re‐operation were not associated with preoperative AT levels. There was no association between TAT, D‐dimer, and anti‐Xa levels at the end of CPB and preoperative AT levels.Conclusion: Low preoperative AT level is associated with increased transfusion of RBC and FFP on CPB in neonates and infants undergoing congenital heart surgery. Low preoperative AT level did not result in coagulation activation after CPB and after surgery.
- 13 December 2019
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 46 (01) , 062-072
Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation
Cardiopulmonary bypass and extracorporeal membrane oxygenation (ECMO) cause hemostatic derangements that can predispose patients to both bleeding and thrombotic complications. Often, patients present for urgent surgery while taking medications including antiplatelet agents, vitamin K antagonists, and direct oral anticoagulants, which must be recognized, monitored, and managed. During extracorporeal circulation, appropriate anticoagulation, most commonly with heparin, is required to maintain blood flow and avoid thrombotic complications. However, anticoagulation and other effects of extracorporeal circuits can also have an undesired consequence of bleeding. Extracorporeal circulation leads to coagulopathy that may require therapy with blood products such as platelets, cryoprecipitate, and plasma in case a patient bleeds. Platelet dysfunction related to exposure to a foreign circuit is a primary concern, as is the development of acquired von Willebrand syndrome, which frequently remains undetected on routine testing. Hemorrhagic complications in ECMO, such as intracranial hemorrhage, pulmonary hemorrhage, and hemithorax, can occur. Hemostatic agents including antifibrinolytics, desmopressin, fibrinogen concentrates, and other factor concentrates may be needed to achieve hemostasis in these often-challenging patients. Managing bleeding on extracorporeal support requires careful monitoring and a thoughtful approach.
- 13 December 2019
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 46 (01) , 062-072
Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation
Cardiopulmonary bypass and extracorporeal membrane oxygenation (ECMO) cause hemostatic derangements that can predispose patients to both bleeding and thrombotic complications. Often, patients present for urgent surgery while taking medications including antiplatelet agents, vitamin K antagonists, and direct oral anticoagulants, which must be recognized, monitored, and managed. During extracorporeal circulation, appropriate anticoagulation, most commonly with heparin, is required to maintain blood flow and avoid thrombotic complications. However, anticoagulation and other effects of extracorporeal circuits can also have an undesired consequence of bleeding. Extracorporeal circulation leads to coagulopathy that may require therapy with blood products such as platelets, cryoprecipitate, and plasma in case a patient bleeds. Platelet dysfunction related to exposure to a foreign circuit is a primary concern, as is the development of acquired von Willebrand syndrome, which frequently remains undetected on routine testing. Hemorrhagic complications in ECMO, such as intracranial hemorrhage, pulmonary hemorrhage, and hemithorax, can occur. Hemostatic agents including antifibrinolytics, desmopressin, fibrinogen concentrates, and other factor concentrates may be needed to achieve hemostasis in these often-challenging patients. Managing bleeding on extracorporeal support requires careful monitoring and a thoughtful approach.
- 18 September 2019
- Published by Wiley in Pediatric Anesthesia
- Vol. 29 (11) , 1086-1093
Neurologic outcomes after heart surgery
- 18 September 2019
- Published by Wiley in Pediatric Anesthesia
- Vol. 29 (11) , 1086-1093
Neurologic outcomes after heart surgery
- 1 August 2018
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 32 (4) , 1657-1663
Preoperative Thromboelastographic Profile of Patients with Congenital Heart Disease: Association of Hypercoagulability and Decreased Heparin Response
- 1 August 2018
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 32 (4) , 1657-1663
Preoperative Thromboelastographic Profile of Patients with Congenital Heart Disease: Association of Hypercoagulability and Decreased Heparin Response
- 1 June 2018
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 32 (3) , 1383-1385
Berlin Heart Explant in an Infant
- 1 June 2018
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 32 (3) , 1383-1385
Berlin Heart Explant in an Infant
- 1 February 2018
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 32 (1) , 395-401
Validation of a Mathematical Model of Bidirectional Glenn Circulation With Aortopulmonary Collaterals and the Implications for Q P /Q S Calculation
- 1 February 2018
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 32 (1) , 395-401
Validation of a Mathematical Model of Bidirectional Glenn Circulation With Aortopulmonary Collaterals and the Implications for Q P /Q S Calculation
- 29 January 2016
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 63 (4) , 507-508
Successful inter-hospital transfer for extracorporeal membrane oxygenation after an amniotic fluid embolism induced cardiac arrest
- 29 January 2016
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 63 (4) , 507-508
Successful inter-hospital transfer for extracorporeal membrane oxygenation after an amniotic fluid embolism induced cardiac arrest